1. Home
  2. RMD vs ALC Comparison

RMD vs ALC Comparison

Compare RMD & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$207.25

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$67.79

Market Cap

35.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMD
ALC
Founded
1989
1945
Country
United States
Switzerland
Employees
10600
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4B
35.9B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
RMD
ALC
Price
$207.25
$67.79
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$292.56
$89.38
AVG Volume (30 Days)
1.3M
2.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.13%
0.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.60
$7.99
Revenue Next Year
$7.41
$6.38
P/E Ratio
$25.61
$38.31
Revenue Growth
N/A
N/A
52 Week Low
$198.61
$61.84
52 Week High
$293.81
$92.55

Technical Indicators

Market Signals
Indicator
RMD
ALC
Relative Strength Index (RSI) 43.72 43.92
Support Level $198.63 $61.84
Resistance Level $260.21 $81.92
Average True Range (ATR) 4.85 1.57
MACD 1.26 0.50
Stochastic Oscillator 62.06 45.77

Price Performance

Historical Comparison
RMD
ALC

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: